P. Karlsson

发表

Comprehensive Transcriptomic Profiling Identifies Breast Cancer Patients Who May Be Spared Adjuvant Systemic Therapy

M. Fernö, F. Feng, E. Davicioni, 2019, Clinical Cancer Research.

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

C. Perou, E. Winer, J. Forbes, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Integrative genomics approach identifies molecular features associated with early-stage ovarian carcinoma histotypes

P. Karlsson, K. Helou, Hanna Engqvist, 2020, Scientific Reports.

Long-term symptoms after radiotherapy of supraclavicular lymph nodes in breast cancer patients.

G. Steineck, E. Holmberg, P. Karlsson, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

J. Cuzick, A. Tutt, C. Denkert, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor–positive Early Breast Cancer: Results from the SOLE Trial

P. Neven, A. Goldhirsch, G. Viale, 2020, Clinical Cancer Research.

A 17-marker panel for global genomic instability in breast cancer.

Toshima Z. Parris, P. Karlsson, K. Helou, 2020, Genomics.

A Novel 18-Marker Panel Predicting Clinical Outcome in Breast Cancer

Toshima Z. Parris, Eva Forssell-Aronsson, G. Steineck, 2017, Cancer Epidemiology, Biomarkers & Prevention.

Novel findings in Swedish patients with MYH-associated polyposis: mutation detection and clinical characterization.

H. Grönberg, G. Kanter-Smoler, R. Hultcrantz, 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

When Is the Deep Inferior Epigastric Artery Flap Indicated for Breast Reconstruction in Patients not Treated With Radiotherapy?

A. Ringberg, T. Hatschek, P. Karlsson, 2014, Annals of plastic surgery.

Postoperative radiotherapy after DCIS: Useful for whom?

P. Karlsson, 2017, Breast.

A diagnostic algorithm to identify paired tumors with clonal origin

Toshima Z. Parris, G. Steineck, P. Karlsson, 2013, Genes, chromosomes & cancer.

Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer.

R. Gelber, B. Gusterson, A. Goldhirsch, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

The impact of age on HHealth-Related Quality of Life (HRQoL) and symptoms among postmenopausal women with breast cancer receiving adjuvant chemotherapy

M. Browall, P. Karlsson, E. Danielson, 2008, Acta oncologica.

A randomised feasibility/phase II study (SBG 2004-1) with dose-dense/tailored epirubicin, cyclophoshamide (EC) followed by docetaxel (T) or fixed dosed dose-dense EC/T versus T, doxorubicin and C (TAC) in node-positive breast cancer

J. Bergh, P. Malmström, S. Margolin, 2011, Acta oncologica.

Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast.

L. Holmberg, K. Sandelin, S. Emdin, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.

E. Winer, J. Cuzick, A. Tutt, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Long-term safety and survival outcomes from the Scandinavian Breast Group 2004-1 randomized phase II trial of tailored dose-dense adjuvant chemotherapy for early breast cancer

J. Bergh, S. Margolin, N. Bengtsson, 2017, Breast Cancer Research and Treatment.

A large deletion disrupts the exon 3 transcription activation domain of the BRCA2 gene in a breast/ovarian cancer family.

A. Wallgren, P. Karlsson, Y. Engwall, 1998, Cancer research.

Transcriptomic and genomic profiling of early-stage ovarian carcinomas associated with histotype and overall survival

Toshima Z. Parris, P. Karlsson, K. Helou, 2018, Oncotarget.

The prognostic relevance of FOXA1 and Nestin expression in breast cancer metastases: a retrospective study of 164 cases during a 10-year period (2004–2014)

Toshima Z. Parris, P. Karlsson, K. Helou, 2019, BMC Cancer.

Reductions in use of hormone replacement therapy: effects on Swedish breast cancer incidence trends only seen after several years

J. Adolfsson, M. Holmqvist, T. Fornander, 2010, Breast Cancer Research and Treatment.

Long-term inequalities in breast cancer survival – a ten year follow-up study of patients managed within a National Health Care System (Sweden)

P. Karlsson, M. Lagerlund, M. Lambe, 2008, Acta oncologica.

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

E. Winer, J. Cuzick, A. Tutt, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Breast cancer survival trends in different stages and age groups – a population-based study 1989–2013

E. Holmberg, P. Karlsson, P. Albertsson, 2018, Acta oncologica.

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial.

P. Neven, R. Gelber, A. Goldhirsch, 2018, The Lancet. Oncology.

Genome-wide multi-omics profiling of the 8p11-p12 amplicon in breast carcinoma

Toshima Z. Parris, Eva Forssell-Aronsson, P. Karlsson, 2018, Oncotarget.

No clear effect of postoperative radiotherapy on survival of breast cancer patients with one to three positive nodes: a population-based study.

B. Nordenskjöld, E. Holmberg, P. Karlsson, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Abstract S3-09: Patient-reported endocrine symptoms, sexual functioning and quality of life (QoL) in the IBCSG SOFT trial: Adjuvant treatment with tamoxifen (T) alone versus tamoxifen plus ovarian function suppression (OFS) in premenopausal women with hormone receptor-po

R. Gelber, H. Burstein, M. Regan, 2015 .

No clear effect of postoperative radiotherapy on survival of breast cancer patients with one to three positive nodes: a population-based study.

B. Nordenskjöld, E. Holmberg, P. Karlsson, 2015 .

Breast cancer risk among Swedish hemangioma patients and possible consequences of radiation-induced genomic instability.

E. Holmberg, P. Karlsson, P. Jacob, 2009, Mutation research.

Cancer incidence after radiotherapy for skin haemangioma during infancy.

A. Wallgren, E. Holmberg, P. Karlsson, 1995, Acta oncologica.

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

Mads Thomassen, Nina Ditsch, Vijai Joseph, 2012, Breast Cancer Research.

Challenges of evaluating a computer‐based educational programme for women diagnosed with early‐stage breast cancer: a randomised controlled trial

F. Ventura, P. Karlsson, I. Koinberg, 2017, European journal of cancer care.

Accelerated partial breast cancer irradiation (APBI)–the future breast cancer radiotherapy?

P. Karlsson, 2009, Acta oncologica.

Symptoms 10-17 years after breast cancer radiotherapy data from the randomised SWEBCG91-RT trial.

G. Steineck, P. Malmström, E. Holmberg, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Toshima Z. Parris, Eva Forssell-Aronsson, P. Karlsson, 2018, Breast Cancer Research.

Phase III randomized study comparing docetaxel plus trastuzumab with vinorelbine plus trastuzumab as first-line therapy of metastatic or locally advanced human epidermal growth factor receptor 2-positive breast cancer: the HERNATA study.

J. Bergh, M. Andersson, A. Jensen, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Excess breast cancer risk and the role of parity, age at first childbirth and exposure to radiation in infancy

A. Mattsson, A. Wallgren, L. Holm, 2001, British Journal of Cancer.

The impact of reproductive factors on breast cancer risk - The feasibility of using Swedish population-based registers to account for the effect of confounding in cohort studies

E. Holmberg, P. Karlsson, H. Anderson, 2005, Cancer Causes & Control.

Prognostic Risk Assessment and Prediction of Radiotherapy Benefit for Women with Ductal Carcinoma In Situ (DCIS) of the Breast, in a Randomized Clinical Trial (SweDCIS)

F. Vicini, G. Mann, K. Sandelin, 2021, Cancers.

Radiation Therapy to the Plexus Brachialis in Breast Cancer Patients: Analysis of Paresthesia in Relation to Dose and Volume.

G. Steineck, E. Holmberg, P. Karlsson, 2015, International journal of radiation oncology, biology, physics.

Design and Creation of a Wearable Circular Ultrasonic Device for a Soft Screening and Diagnosis of Breast Abnormalities

P. Karlsson, K. Helou, G. Nassar, 2019, Journal of Cancer Science and Clinical Therapeutics.

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2mutation carriers

V. Pankratz, F. Couch, B. Bonanni, 2012, Breast Cancer Research.

A founder mutation of the BRCA1 gene in Western Sweden associated with a high incidence of breast and ovarian cancer

A. Wallgren, P. Karlsson, L. Kindblom, 2001 .

Continuous vs intermittent extended adjuvant letrozole for breast cancer: Final results of randomized phase 3 SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy.

P. Neven, S. Loi, S. Loibl, 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial

P. Neven, R. Gelber, H. Gómez, 2019, British Journal of Cancer.

Reply to 'The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology' by Kirova et al.

E. Winer, J. Cuzick, A. Tutt, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Distribution of locoregional breast cancer recurrence in relation to postoperative radiation fields and biological subtypes.

F. Killander, E. Holmberg, P. Karlsson, 2019, International journal of radiation oncology, biology, physics.

Pan-cancer analysis of genomic and transcriptomic data reveals the prognostic relevance of human proteasome genes in different cancer types

Toshima Z. Parris, Eva Forssell-Aronsson, P. Karlsson, 2022, BMC Cancer.

Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V.

Per Karlsson, Zhuoxin Sun, J. Forbes, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Association of Nuclear-Localized Nemo-Like Kinase with Heat-Shock Protein 27 Inhibits Apoptosis in Human Breast Cancer Cells

U. Hellman, R. Massoumi, P. Karlsson, 2014, PloS one.

Estimating the Risk for Secondary Cancer After Targeted α-Therapy with 211At Intraperitoneal Radioimmunotherapy

E. Holmberg, P. Karlsson, P. Albertsson, 2022, The Journal of Nuclear Medicine.

Title Interplay between BRCA 1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer

Loris, Fiona, Meindl, 2012 .

Occurrence of both breast and ovarian cancer in a woman is a marker for the BRCA gene mutations: a population-based study from Western Sweden

A. Wallgren, P. Karlsson, L. Kindblom, 2006, Familial Cancer.

Integration of biological factors in the treatment plan evaluation in breast cancer radiotherapy

P. Karlsson, D. Lundstedt, M. Gustafsson, 2019, Physics and imaging in radiation oncology.

Population study on brca mutations in women with breast and ovarian cancers in western Sweden

A. Wallgren, P. Karlsson, L. Kindblom, 2003 .

BRCA1 gene mutations may explain more than 80% of excess number of ovarian cancer cases after breast cancer – a population based study from the Western Sweden Health Care region

A. Wallgren, P. Karlsson, C. Enerbäck, 2010, Acta oncologica.

Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group report.

J. Forbes, R. Gelber, A. Goldhirsch, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial.

P. Neven, R. Gelber, A. Goldhirsch, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas

P. Karlsson, K. Helou, S. Nemes, 2019, BMC Cancer.

Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome

Per Karlsson, Toshima Z. Parris, Zakaria Einbeigi, 2013, BMC Cancer.

Intracranial tumors after radium treatment for skin hemangioma during infancy--a cohort and case-control study.

C. Nordborg, A. Wallgren, E. Holmberg, 1997, Radiation research.

Soft tissue sarcoma after treatment for breast cancer.

J. Carstensen, A. Wallgren, E. Holmberg, 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Soft tissue sarcoma after treatment for breast cancer--a Swedish population-based study.

A. Wallgren, E. Holmberg, P. Karlsson, 1998, European journal of cancer.

Prognostic and predictive impact of stroma cells defined by PDGFRb expression in early breast cancer: results from the randomized SweBCG91RT trial

M. Fernö, L. Akslen, P. Malmström, 2021, Breast Cancer Research and Treatment.

Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study

V. Pankratz, F. Couch, B. Bonanni, 2012, British Journal of Cancer.

Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2

Mads Thomassen, Stephen Fox, Dieter Niederacher, 2011, Breast Cancer Research.

High-resolution genomic profiling to predict 10-year overall survival in node-negative breast cancer.

Toshima Z. Parris, B. Olsson, P. Karlsson, 2010, Cancer genetics and cytogenetics.

A high frequency of germline BRCA1/2 mutations in western Sweden detected with complementary screening techniques

P. Karlsson, Z. Einbeigi, Y. Engwall, 2004, Familial Cancer.

Clinical relevance of breast cancer-related genes as potential biomarkers for oral squamous cell carcinoma

Toshima Z. Parris, P. Karlsson, K. Helou, 2014, BMC Cancer.

Integrative genomics approach identifies molecular features associated with early-stage ovarian carcinoma histotypes

Toshima Z. Parris, P. Karlsson, K. Helou, 2020, Scientific Reports.

Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers

Peter Devilee, Alfons Meindl, Lesley McGuffog, 2010, Breast Cancer Research.

Trefoil factor family proteins as potential diagnostic markers for mucinous invasive ovarian carcinoma

Toshima Z. Parris, P. Dahm-Kähler, P. Karlsson, 2023, Frontiers in Oncology.

Optimization of cell viability assays to improve replicability and reproducibility of cancer drug sensitivity screens

Eva Forssell-Aronsson, Per Karlsson, Toshima Z. Parris, 2020, Scientific Reports.

Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS Trial.

L. Holmberg, K. Jirström, K. Sandelin, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clustering of Individuals with both Breast and Ovarian Cancer: A Possible Indicator of BRCA Founder Mutations

A. Wallgren, P. Karlsson, L. Kindblom, 2002, Acta oncologica.

Frequent MYC coamplification and DNA hypomethylation of multiple genes on 8q in 8p11-p12-amplified breast carcinomas

Toshima Z. Parris, P. Karlsson, K. Helou, 2014, Oncogenesis.

Chromosomal changes associated with clinical outcome in lymph node-negative breast cancer.

B. Olsson, P. Karlsson, K. Helou, 2007, Cancer genetics and cytogenetics.

Comparative genome hybridization reveals specific genomic imbalances during the genesis from benign through borderline to malignant ovarian tumors.

T. Ried, T. Knutsen, P. Karlsson, 2006, Cancer genetics and cytogenetics.

Up-regulation of cell cycle arrest protein BTG2 correlates with increased overall survival in breast cancer, as detected by immunohistochemistry using tissue microarray

Szilard Nemes, Per Karlsson, Karin Jirström, 2010, BMC Cancer.

Clinical Implications of Gene Dosage and Gene Expression Patterns in Diploid Breast Carcinoma

Per Karlsson, Toshima Z. Parris, Khalil Helou, 2010, Clinical Cancer Research.

Genetic alterations associated with multiple primary malignancies

Toshima Z. Parris, Eva Forssell-Aronsson, P. Karlsson, 2021, Cancer medicine.

Radiation‐induced genomic instability in breast carcinomas of the Swedish hemangioma cohort

Toshima Z. Parris, E. Holmberg, P. Karlsson, 2019, Genes, chromosomes & cancer.

Mindfulness and its efficacy for psychological and biological responses in women with breast cancer

P. Karlsson, E. Kenne Sarenmalm, B. Andersson, 2017, Cancer medicine.

Tumour-infiltrating lymphocytes add prognostic information for patients with low-risk DCIS: findings from the SweDCIS randomised radiotherapy trial.

H. Olofsson, E. Holmberg, P. Karlsson, 2022, European journal of cancer.

Breast cancer risk and possible mechanisms of radiation-induced genomic instability in the Swedish hemangioma cohort after reanalyzed dosimetry.

E. Holmberg, P. Karlsson, P. Jacob, 2015, Mutation research.

Prognostic Significance of BIRC5/Survivin in Breast Cancer: Results from Three Independent Cohorts

Toshima Z. Parris, N. Oparina, P. Karlsson, 2021, Cancers.

No breast cancer subgroup can be spared postoperative radiotherapy after breast-conserving surgery. Fifteen-year results from the Swedish Breast Cancer Group randomised trial, SweBCG 91 RT.

L. Holmberg, P. Malmström, F. Killander, 2016, European journal of cancer.

Additive effect of the AZGP1, PIP, S100A8 and UBE2C molecular biomarkers improves outcome prediction in breast carcinoma

Toshima Z. Parris, Eva Forssell-Aronsson, P. Karlsson, 2014, International journal of cancer.

Intracranial tumors after exposure to ionizing radiation during infancy: a pooled analysis of two Swedish cohorts of 28,008 infants with skin hemangioma.

A. Mattsson, A. Wallgren, L. Holm, 1998, Radiation research.

The western Swedish BRCA1 founder mutation 3171ins5; a 3.7 cM conserved haplotype of today is a reminiscence of a 1500-year-old mutation

A. Wallgren, P. Karlsson, Z. Einbeigi, 2001, European Journal of Human Genetics.

Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

W. Chung, V. Pankratz, F. Couch, 2012, Cancer Epidemiology, Biomarkers & Prevention.

Evidence for Increased Susceptibility to Breast Cancer From Exposure to Ionizing Radiation Due to a Familial History of Breast Cancer: Results From the Swedish Hemangioma Cohort

E. Holmberg, P. Karlsson, M. Lundell, 2020, American journal of epidemiology.

Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.

Mads Thomassen, Nina Ditsch, Dieter Niederacher, 2009, Human molecular genetics.

Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers.

F. Couch, B. Karlan, J. Benítez, 2011, Journal of the National Cancer Institute.

Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer.

A. Giobbie-Hurder, R. Gelber, B. Gusterson, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers.

F. Couch, T. Rebbeck, J. Benítez, 2011, Human molecular genetics.

Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer

Marc Vidal, Dieter Niederacher, Roderic Guigó, 2011, PLoS biology.

Clinical characterization and the mutation spectrum in Swedish adenomatous polyposis families

H. Grönberg, G. Kanter-Smoler, P. Karlsson, 2008, BMC medicine.

No germline mutations in supposed tumour suppressor genes SAFB1 and SAFB2 in familial breast cancer with linkage to 19p

P. Karlsson, A. Behboudi, M. Nordling, 2008, BMC Medical Genetics.

Genome‐wide linkage scan for breast cancer susceptibility loci in Swedish hereditary non‐BRCA1/2 families: Suggestive linkage to 10q23.32‐q25.3

A. Wallgren, P. Karlsson, S. Nilsson, 2007, Genes, chromosomes & cancer.

Outcome of reproduction in women irradiated for skin hemangioma in infancy.

B. Källén, A. Wallgren, L. Holm, 1998, Radiation research.

Breast cancer risk after radiotherapy in infancy: a pooled analysis of two Swedish cohorts of 17,202 infants.

A. Gustafsson, A. Mattsson, L. Holm, 1999, Radiation research.

Breast Cancer Risk and 6q22.33: Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2

S. Seal, N. Rahman, D. Noh, 2012, PloS one.

Breast Cancer Risk and 6 q 22 . 33 : Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA 1 / 2

S. Seal, N. Rahman, D. Noh, 2012 .

Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IX.

R. Gelber, B. Gusterson, A. Goldhirsch, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Development and Validation of a Genomic Profile for the Omission of Local Adjuvant Radiation in Breast Cancer

M. Fernö, P. Malmström, F. Feng, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Risk factors of developing long-lasting breast pain after breast cancer radiotherapy.

G. Steineck, P. Malmström, E. Holmberg, 2012, International journal of radiation oncology, biology, physics.

Dose–Response Relationship for Parathyroid Adenoma after Exposure to Ionizing Radiation in Infancy

A. Wallgren, L. Holm, E. Holmberg, 2002, Radiation research.

Validation of Novel Prognostic Biomarkers for Early-Stage Clear-Cell, Endometrioid and Mucinous Ovarian Carcinomas Using Immunohistochemistry

Toshima Z. Parris, P. Karlsson, K. Helou, 2020, Frontiers in Oncology.

Discovery and validation of a genomic signature to identify women with early-stage invasive breast cancer who may safely omit adjuvant radiotherapy after breast-conserving surgery.

M. Fernö, F. Feng, L. Pierce, 2021 .

Immune Infiltrate in the Primary Tumor Predicts Effect of Adjuvant Radiotherapy in Breast Cancer; Results from the Randomized SweBCG91RT Trial

F. Feng, L. Pierce, C. Speers, 2020, Clinical Cancer Research.

Clinicogenomic Radiotherapy Classifier Predicting the Need for Intensified Locoregional Treatment After Breast-Conserving Surgery for Early-Stage Breast Cancer

M. Fernö, F. Feng, E. Davicioni, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of Radiotherapy After Breast-Conserving Surgery Depending on the Presence of Tumor-Infiltrating Lymphocytes: A Long-Term Follow-Up of the SweBCG91RT Randomized Trial.

M. Fernö, P. Malmström, P. Malmström, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Response to Radiotherapy After Breast-Conserving Surgery in Different Breast Cancer Subtypes in the Swedish Breast Cancer Group 91 Radiotherapy Randomized Clinical Trial.

M. Fernö, F. Killander, P. Malmström, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gene expression variation to predict 10-year survival in lymph-node-negative breast cancer

Björn Olsson, Elin Karlsson, Per Karlsson, 2008, BMC Cancer.

q 31 . 2 and in ZNF 365 are associated with breast cancer risk for BRCA 1 and / or BRCA 2 mutation carriers

V. Pankratz, F. Couch, B. Bonanni, 2012 .

Gene expression profiling in primary breast cancer distinguishes patients developing local recurrence after breast-conservation surgery, with or without postoperative radiotherapy

Carsten Peterson, Mårten Fernö, Morten Krogh, 2008, Breast Cancer Research.

The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer.

J. Forbes, R. Gelber, B. Gusterson, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High PDGFRb Expression Predicts Resistance to Radiotherapy in DCIS within the SweDCIS Randomized Trial

J. Bergh, L. Akslen, E. Holmberg, 2021, Clinical Cancer Research.

Socio-economic factors and breast cancer survival – a population-based cohort study (Sweden)

P. Karlsson, M. Lagerlund, M. Lambe, 2005, Cancer Causes & Control.

Evidence for SMAD 3 as a modifier of breast cancer risk in BRCA 2 mutation carriers

V. Pankratz, F. Couch, T. Rebbeck, 2010 .

Breast cancer hypoxia in relation to prognosis and benefit from radiotherapy after breast-conserving surgery in a large, randomised trial with long-term follow-up

M. Fernö, P. Malmström, F. Killander, 2022, British Journal of Cancer.

Mammography casting-type calcification and risk of local recurrence in DCIS: analyses from a randomised study

L. Tabár, L. Holmberg, K. Sandelin, 2013, British Journal of Cancer.

Bilateral Prophylactic Mastectomy in Swedish Women at High Risk of Breast Cancer: A National Survey

N. Loman, K. Sandelin, A. Ringberg, 2011, Annals of surgery.

M. Browall, P. Karlsson, E. Danielson, 2008, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

Optimization of cell viability assays to improve replicability and reproducibility of cancer drug sensitivity screens

Eva Forssell-Aronsson, P. Karlsson, K. Helou, 2020, Scientific Reports.

Previously diagnosed multiple primary malignancies in patients with breast carcinoma in Western Sweden between 2007 and 2018

Toshima Z. Parris, P. Karlsson, K. Helou, 2020, Breast Cancer Research and Treatment.

Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapy.

A. Goldhirsch, K. Price, M. Castiglione‐Gertsch, 2011, International journal of radiation oncology, biology, physics.

Inactivation of promoter 1B of APC causes partial gene silencing: evidence for a significant role of the promoter in regulation and causative of familial adenomatous polyposis

P. Karlsson, M. Nilbert, Z. Einbeigi, 2011, Oncogene.

No increased cardiac mortality or morbidity of radiotherapy in breast cancer patients after breast conserving surgery: 20 years follow-up of the randomised x trial.

L. Holmberg, P. Malmström, E. Wieslander, 2020, International journal of radiation oncology, biology, physics.

Timing of Radiation Therapy and Chemotherapy After Breast-Conserving Surgery for Node-Positive Breast Cancer: Long-Term Results From International Breast Cancer Study Group Trials VI and VII.

R. Gelber, A. Goldhirsch, M. Castiglione, 2016, International journal of radiation oncology, biology, physics.

Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial

P. Neven, R. Gelber, H. Gómez, 2019, British Journal of Cancer.

Adjuvant ovarian function suppression and cognitive function in women with breast cancer

J. Forbes, R. Gelber, P. Maruff, 2016, British Journal of Cancer.

No clinically relevant effect on cognitive outcomes after low-dose radiation to the infant brain: A population-based cohort study in Sweden

K. Blomgren, T. Björk-Eriksson, M. Åberg, 2014, Acta oncologica.

Locally advanced breast cancer

S. Aebi, P. Karlsson, I. Wapnir, 2021, Breast.

Clinical evaluation of molecular surrogate subtypes in patients with ipsilateral multifocal primary breast cancer

R. Audisio, P. Karlsson, T. Parris, 2023, Breast Cancer Research.

Survival patterns of invasive lobular and invasive ductal breast cancer in a large population-based cohort with two decades of follow up

B. Nordenskjöld, E. Holmberg, P. Karlsson, 2021, Breast.

Correction to: De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28(8) (1700–1712), (S0923753419321817), (10.1093/annonc/mdx308))

E. Winer, J. Cuzick, J. Bergh, 2017 .

Genomic characterisation of hormone receptor-positive breast cancer arising in very young women.

P. Neven, S. Loi, S. Nik-Zainal, 2023, Annals of oncology : official journal of the European Society for Medical Oncology.

Adjuvant Radiation Treatment of Breast Cancer After Mastectomy: Advanced Algorithms and Partial Bolus Improve the Dose Calculation Accuracy in the Case of Thin-Chest-Wall Irradiation

P. Karlsson, D. Lundstedt, M. Gustafsson, 2023, Advances in radiation oncology.

Metachronous and Synchronous Occurrence of 5 Primary Malignancies in a Female Patient between 1997 and 2013: A Case Report with Germline and Somatic Genetic Analysis

Fredrik Persson, Åke Borg, Per Karlsson, 2017, Case Reports in Oncology.

Daily assessment of stressful events and coping among post-menopausal women with breast cancer treated with adjuvant chemotherapy.

M. Browall, P. Karlsson, E. Danielson, 2009, European journal of cancer care.

Radiotherapy for Metastatic Lesions

P. Karlsson, D. Lundstedt, 2017 .

Prevalence of Cancer in Patients with Venous Thromboembolism: A Retrospective Nationwide Case-Control Study in Sweden

A. Rosengren, P. Karlsson, P. Hansson, 2023, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Eva Forssell-Aronsson, P. Karlsson, K. Helou, 2018, Breast Cancer Research.

Expression of HGF, pMet, and pAkt is related to benefit of radiotherapy after breast‐conserving surgery: a long‐term follow‐up of the SweBCG91‐RT randomised trial

M. Fernö, O. Stål, F. Killander, 2020, Molecular oncology.

Clinical relevance of biomarker discordance between primary breast cancers and synchronous axillary lymph node metastases

Toshima Z. Parris, R. Audisio, P. Karlsson, 2023, Clinical & Experimental Metastasis.

Positive sentinel node in luminal A-like breast cancer patients - implications for adjuvant chemotherapy?

P. Karlsson, D. Lundstedt, R. Olofsson Bagge, 2018, Acta oncologica.

Clinical characterization and the mutation spectrum in Swedish adenomatous polyposis families

H. Grönberg, G. Kanter-Smoler, P. Karlsson, 2008, BMC medicine.

Combining histological grade, TILs, and the PD-1/PD-L1 pathway to identify immunogenic tumors and de-escalate radiotherapy in early breast cancer: a secondary analysis of a randomized clinical trial

F. Killander, E. Holmberg, P. Karlsson, 2023, Journal for ImmunoTherapy of Cancer.

Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas